Biolux Australia Pty Limited

Status: Registered
Australian Company Number: 168921373
Australian Business Number: 29168921373
Registration date: Thursday 3rd April 2014
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


Biolux Australia Pty Limited is a limited by shares Australian proprietary company. Located at NSW 2028 since 2014-04-03 the company is, as the updated on 2014-04-07 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2014-04-03. Known company numbers for Biolux Australia Pty Limited are as follows: ACN - 168921373, Australian Business Number - 29168921373. Orthopulse Io is an example of a business name Biolux Australia Pty Limited used. The complete list includes 1 solitary business name. Orthopulse Io was the company's business name from 2014-04-07. We found 0 trademarks that reference this company.


Details for ABN 29168921373

Type: Australian Private Company

ABN Status

Status From To
Active Thursday 3rd April 2014 current

Main Name

Name From To
Biolux Australia Pty Limited Thursday 3rd April 2014 current

Business Names

Name From To
Orthopulse Io Monday 7th April 2014 current

Main Location

Location From To
NSW 2028 Thursday 3rd April 2014 current

Goods & Services Tax (GST)

Status From To
Registered Thursday 3rd April 2014 current


Find company

NSW 2028 Location

2016 © - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us:
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2015 (, and, ©Intellectual Property Government Open Data 2015, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.